|
C.QNTM
|
Nobel laureate Rita Levi-Montalcini described the importance of the...
|
|
C.QNTM
|
PEA acts via multiple mechanisms either directly to activate PPAR-α and GPR55...
|
|
C.QNTM
|
The primary endpoint is to determine if FSD-201 plus SOC provides a...
|
|
C.QNTM
|
"FDA's permission to design a proof-of-concept study in COVID-19...
|
|
C.QNTM
|
the U.S. Food and Drug Administration (FDA) has given the company permission...
|
|
C.TRIP
|
People often report that the magic truffles trip is a less intense, shorter...
|
|
C.TRIP
|
Magic truffles (when dried) contain a lower concentration of psilocybin than...
|
|
C.TRIP
|
Magic truffles are related to the more well-known psychedelic, magic...
|
|
C.TRIP
|
proposed offering of 30,304,000 units (the “Units”) at an offering price of...
|
|
C.TRIP
|
Magic truffles, which are sold in their natural, raw and unprocessed form...
|
|
V.GRAT
|
Third party characterization and testing of the Aukam graphite shows that it...
|
|
V.GRAT
|
The Aukam Graphite Project is located in southern Namibia close to the port...
|
|
V.GRAT
|
In addition to the underground workings on the property, there are five...
|
|
V.GRAT
|
The Aukam property covers a historical vein graphite mine that consists of...
|
|
C.QNTM
|
FSD Pharma acquired worldwide rights (ex-Italy and Spain) to...
|
|
C.QNTM
|
Nobel laureate Rita Levi-Montalcini described the importance of the...
|
|
C.QNTM
|
AEA has been shown to inhibit tumor necrosis factor-α-induced NF-kappa B...
|
|
C.QNTM
|
In Q220, the Company continued to strengthen available cash on hand through...
|
|
C.QNTM
|
The Phase 1 first-in-human safety and tolerability study with ultramicronized...
|
|
C.TRIP
|
Most people have heard of ‘magic mushrooms’, but they may be unfamiliar with...
|